Redwood Ttm Ltd

Redwood TTM Ltd is a specialized manufacturer of high-performance technical textiles, primarily serving the medical and retail sectors with custom solutions for pressure area care mattresses and advanced textile applications. Founded in 1994, Redwood TTM specializes in the production of technical textiles. The company has maintained a consistent focus on high-performance materials and has seen no significant pivots in its operations. It operates from its headquarters in the UK and caters to clients globally, including in Europe and North America.

The company's founder has a history of successful ventures in the textile industry, although specific prior company details are not available. Redwood TTM specializes in high-performance technical textiles, primarily serving the medical, retail, and contract bedding sectors. The company’s core offerings include bespoke pressure area care mattresses that comply with stringent medical device regulations, along with specialized fabrics suitable for various applications, including fire-retardant and antimicrobial textiles. Manufacturing capabilities include fabric welding, precision cutting, and quilting, ensuring customized solutions for their clients.

The client base encompasses medical manufacturers, retailers, and other businesses requiring high-quality textiles, with products distributed internationally, addressing needs in acute medical environments and retail bedding sectors. Redwood TTM generates revenue through business-to-business transactions, providing tailored textile solutions directly to medical manufacturers and retailers. The company engages in contracts for bespoke mattress manufacturing and fabric sourcing, fostering partnerships that promote ongoing collaboration and innovation. The revenue model focuses on unit sales of specialized products, notably their flagship Verituss mattresses for the healthcare sector, with pricing reflecting the complexity of designs and materials used.

Redwood TTM is focused on expanding its product range, particularly in developing new types of mattresses and textiles designed for enhanced medical applications. The company is also exploring entry into Asia-Pacific markets by 2025, aiming to increase its global footprint. Recent funding will be utilized to support research and development initiatives related to these product expansions and market entries.